These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10603626)

  • 1. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands.
    Rutten-van Mölken MP; Postma MJ; Joore MA; Van Genugten ML; Leidl R; Jager JC
    Respir Med; 1999 Nov; 93(11):779-87. PubMed ID: 10603626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.
    van den Boom G; van Schayck CP; van Möllen MP; Tirimanna PR; den Otter JJ; van Grunsven PM; Buitendijk MJ; van Herwaarden CL; van Weel C
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1730-8. PubMed ID: 9847260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.
    Feenstra TL; van Genugten ML; Hoogenveen RT; Wouters EF; Rutten-van Mölken MP
    Am J Respir Crit Care Med; 2001 Aug; 164(4):590-6. PubMed ID: 11520721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Projections of future resource use and the costs of asthma and COPD in the Netherlands].
    Hoogendoorn M; Feenstra TL; Rutten-van Mölken MP
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1243-50. PubMed ID: 16796176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands.
    Rutten van-Mölken MP; Feenstra TL
    Pharmacoeconomics; 2001; 19 Suppl 2():1-6. PubMed ID: 11700783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic population model of disease progression in COPD.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; van Genugten ML; Buist AS; Wouters EF; Feenstra TL
    Eur Respir J; 2005 Aug; 26(2):223-33. PubMed ID: 16055869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
    Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B
    Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide + formoterol delivered via Spiromax
    Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population.
    Stang P; Lydick E; Silberman C; Kempel A; Keating ET
    Chest; 2000 May; 117(5 Suppl 2):354S-9S. PubMed ID: 10843976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Costs of illness for asthma and COPD in adults in Germany].
    Kirsch F; Teuner CM; Menn P; Leidl R
    Gesundheitswesen; 2013 Jul; 75(7):413-23. PubMed ID: 23553190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 Behavioral Risk Factor Surveillance System.
    Schauer GL; Wheaton AG; Malarcher AM; Croft JB
    COPD; 2014 Dec; 11(6):697-704. PubMed ID: 24841392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference?
    Mohangoo AD; van der Linden MW; Schellevis FG; Raat H
    Eur J Public Health; 2006 Feb; 16(1):101-5. PubMed ID: 16141304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Societal costs of asthma, COPD and respiratory allergy].
    Suijkerbuijk AW; de Wit GA; Wijga AH; Heijmans M; Hoogendoorn M; Rutten-van Mölken M; Maurits EE; Hoogenveen RT; Feenstra TL
    Ned Tijdschr Geneeskd; 2013; 157(46):A6562. PubMed ID: 24220178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.
    Sadatsafavi M; Tavakoli H; Kendzerska T; Gershon A; To T; Aaron SD; FitzGerald JM;
    Ann Am Thorac Soc; 2016 Feb; 13(2):188-96. PubMed ID: 26599154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of chronic obstructive pulmonary disease (COPD).
    Viegi G; Scognamiglio A; Baldacci S; Pistelli F; Carrozzi L
    Respiration; 2001; 68(1):4-19. PubMed ID: 11223724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smoking.
    Jindal SK; Aggarwal AN; Gupta D
    Indian J Chest Dis Allied Sci; 2001; 43(3):139-47. PubMed ID: 11529432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
    Cedillo S; Sicras-Mainar A; Jiménez-Ruiz CA; Fernández de Bobadilla J; Rejas-Gutiérrez J
    Eur Addict Res; 2017; 23(1):7-18. PubMed ID: 27794567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007.
    Laitinen LA; Koskela K
    Respir Med; 1999 May; 93(5):297-332. PubMed ID: 10464898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.